Active, Not Recruiting
A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia
NCT06199089
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
- Locations
-
- Chinese Academy of Medical Science and Blood Disease Hospital Tianjin, Tianjin Municipality, China